BPC-157

What it is

BPC-157 is a lab-made chain of 15 amino acids based on a protective compound found in human stomach juice - which is why it survives stomach acid for over 24 hours, unusual for a peptide. In animal studies it appears to help injured tissue heal by boosting nitric oxide signaling and VEGF (a growth factor that builds new blood vessels) while calming inflammation. It has been tested in rats and dogs for tendon, ligament, muscle, gut, and nerve injuries with consistently positive results and no identified toxic dose. The catch: almost all of this evidence is preclinical, not human. Human evidence is thin - a 2015 Phase I trial was never completed and published. It is not FDA-approved and is banned for competitive athletes by WADA. People using it outside a study are working from animal data and community experience, not an established human dose.

Dose ranges

Study-backed ranges carry a source you can open. Community ranges are widely reported but not clinically established - treat them as what people do, not as advice.

Reconstitution & storage

Vendor convention, not a manufacturer standard - no FDA-approved BPC-157 product exists. Common charts list 2 mL bacteriostatic water for 5-10 mg vials (2.5-5 mg/mL) and 3 mL for larger vials. Let the vial reach room temperature, inject the water slowly down the inside wall, and swirl gently rather than shaking.

Common stacks

Interactions & cautions

No human drug-interaction studies exist - what follows is animal data plus community caution, not clinical guidance. In rats, BPC-157 counteracted the bleeding effects of heparin and warfarin, which shows it clearly interacts with clotting pathways; anyone on an anticoagulant or antiplatelet drug should talk to a doctor before combining. Preclinical reviews raise two theoretical concerns: an effect on nitric oxide signaling that could touch drugs metabolized via cytochrome P450, and pro-angiogenic (blood-vessel-building) activity that is a theoretical concern for anyone with active cancer or a cancer history. BPC-157 can cause injection-site pain in plain aqueous solution. It is not FDA-approved, so there is no official interaction list to defer to.

Questions people ask

Sources

1. [1]Pharmacokinetics, distribution, metabolism, and excretion of BPC 157 in rats and dogs PMID 36588717studyBPC-157 plasma elimination half-life is under 30 minutes in both rats and dogs across IV and IM routes, with linear pharmacokinetics at all doses tested.
2. [2]Multifunctionality and Possible Medical Application of the BPC 157 Peptide - Literature and Patent Review PMID 40005999reviewCompiles preclinical dose ranges (10 mcg/kg/day rat muscle-injury; 100-500 mcg/kg/day 28-day dog toxicity study with no adverse effects), notes injection-site pain in plain aqueous solution, and confirms a 2015 human Phase I trial was cancelled before publication.
3. [3]The Stable Gastric Pentadecapeptide BPC 157: Pleiotropic Activity and Neurotransmitter RelationsreviewDescribes BPC-157's proposed mechanism through VEGF and nitric-oxide signaling and its modulation of dopamine and serotonin systems across animal models.
4. [4]Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia in Rats Treated with Heparin and WarfarinstudyIn rats, BPC-157 (10 mcg/kg or 10 ng/kg) counteracted heparin- and warfarin-induced bleeding and thrombocytopenia, demonstrating a direct interaction with anticoagulant drug effects.
5. [5]BPC-157: A Prohibited Peptide and an Unapproved Drug (Operation Supplement Safety, DoD)regulatoryConfirms BPC-157 is on WADA's S0 prohibited list and the US DoD prohibited supplement list, and that the FDA has cautioned against compounded BPC-157 products due to safety and contamination risks.
6. [6]How to Reconstitute BPC-157: BAC Water Chart (community guide)communityVendor reconstitution chart: 2 mL bacteriostatic water for 5-10 mg vials (2.5-5 mg/mL) and 3 mL for larger vials.
7. [7]BPC-157 Dosage Guide (community)communityReports commonly discussed human self-dosing of 200-750 mcg/day depending on goal, with typical cycle lengths of 2-8 weeks.